Last week we announced our Series C funding round of $101M, led by world-renowned venture capital firm General Catalyst.
This funding will enable BrightInsight to accelerate its hypergrowth as it continues to expand its team, further differentiate its proven platform technology and support its customers’ digital health product launches globally. The Series C included strong participation from existing investors including Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies, New Leaf Venture Partners, a leading healthcare technology venture capital firm, and Eclipse Ventures, which invests in the digital transformation of essential industries.
Our Series C financing round not only validates the market need for a global digital health platform for biopharma and medtech, but also reinforces the tremendous progress we have made in establishing BrightInsight as a proven, compliant platform that significantly speeds time to market for our biopharma and medtech customers.
We wanted to share this fun 4-minute video featuring our co-founders, board members and pictures of how our amazing team members celebrated the Series C.
Cheers to our team and big thanks to our Investors!